Teva, Viatris win new chance to challenge J&J schizophrenia drug patent
By Blake Brittain (Reuters) -Teva Pharmaceutical and Viatris convinced a U.S. appeals court on Monday to revive their challenges to…
Global equity funds draw inflows for fifth week in a row
(Reuters) – Global equity funds attracted inflows for a fifth successive week in the seven days to March 27 as…
Investors eye Fed rate cut, earnings as key to sustaining market rally
By David Randall NEW YORK (Reuters) -After a stellar start to the year for stocks, investors are on guard for…
New US inflation data ‘along the lines’ of what Fed wants, Powell says
By Howard Schneider and Ann Saphir WASHINGTON (Reuters) -The latest U.S. inflation data is “along the lines of what we…
With China EV launch, Xiaomi’s ‘Thor’ takes on Elon Musk
By Sarah Wu BEIJING (Reuters) -He was called China’s answer to Steve Jobs for taking Xiaomi from scrappy startup to…
Ukraine gets $1.5 billion funding tranche under World Bank programme
(Reuters) -Ukraine has received a $1.5 billion tranche of funding under a World Bank programme, Prime Minister Denys Shmyhal said…
Oil rises more than $1 a barrel on tighter supply outlook
By Laila Kearney NEW YORK (Reuters) -Oil prices jumped more than $1 a barrel on Thursday, closing out the month…
Citi says 42% of energy clients lack climate transition plans
By Isla Binnie NEW YORK (Reuters) – Almost half of the energy companies Citi lends to are lacking plans to…
Home Depot bulks up Pro-business with $18.25 billion deal for building products supplier SRS
By Deborah Mary Sophia, Savyata Mishra and Abigail Summerville (Reuters) -Home Depot will buy building materials supplier SRS Distribution in…
Walgreens takes $5.8 billion hit on VillageMD bet amid CEO focus on profit
By Leroy Leo and Puyaan Singh (Reuters) -Walgreens Boots Alliance recorded a $5.8 billion impairment charge on its investment in…